Dr Reddy’s receives EUA for Sputnik V in India
Sputnik V uses two different vectors for the two shots in a course of vaccination and its efficacy was determined to be 91.6 per…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun…
ABCD Technologies buys 66.02 per cent stake in AWACS
The acquisition of 33.44 per cent of the shareholding in AWACS (indirect) is envisaged to be completed over the course of the next…
Dr Reddy’s announces secondary listing of ADRs on NSE IFSC, GIFT City, Gujarat
This is a secondary listing of ADRs that are currently issued by J.P. Morgan Chase Bank NA under its ADR Deposit agreement with Dr…
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V…
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study
Dr Reddy’s signs agreement with FUJIFILM and Global Response Aid for Avigan (favipiravir)
Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.
FDA approves Dr Reddy’s NDA for migraine drug
The company is working to commercialise Elyxyb (previously known as DFN-15), which is indicated for the acute treatment of…
Dr Reddy’s launches generic hemophilia injection in US
The company has launched desmopressin acetate injection USP, 4 mcg/mL single-dose ampules in the US market, Dr Reddy''s…
While the market is bleeding, pharma sector has withstood the lock-down. Can it be a good bet for…
Rahul Agarwal, Director, Wealth Discovery, explains how the once beaten-down sector, has recently witnessed sharp uptick with…
Dr Reddy’s Laboratories announces the launch of Invista (dasatinib) in India
It is indicated for the treatment of chronic accelerated or myeloid or lymphoid blast phase and newly diagnosed in chronic phase…